Treatment of FANCA Cells with Resveratrol and N-Acetylcysteine: A Comparative Study
暂无分享,去创建一个
P. Degan | C. Capanni | I. Panfoli | S. Ravera | M. Columbaro | E. Cappelli | P. Cuccarolo | G. Stroppiana | Paola Cuccarolo
[1] M. Grompe,et al. Evaluation of resveratrol and N‐acetylcysteine for cancer chemoprevention in a Fanconi anemia murine model , 2014, Pediatric blood & cancer.
[2] B. Bay,et al. Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi Anemia cells , 2014, Oncogene.
[3] P. Degan,et al. Mitochondrial respiratory chain Complex I defects in Fanconi anemia complementation group A. , 2013, Biochimie.
[4] P. Degan,et al. Changes in vimentin, lamin A/C and mitofilin induce aberrant cell organization in fibroblasts from Fanconi anemia complementation group A (FA-A) patients. , 2013, Biochimie.
[5] P. Degan,et al. Mitochondrial respiratory complex I defects in Fanconi anemia. , 2013, Trends in molecular medicine.
[6] M. Rath,et al. In vitro and in vivo inhibition of human Fanconi anemia-associated head and neck squamous cell carcinoma by a novel nutrient mixture , 2012, International Journal of Oncology.
[7] M. Los,et al. Mitoptosis, a Novel Mitochondrial Death Mechanism Leading Predominantly to Activation of Autophagy , 2012, Hepatitis monthly.
[8] P. Degan,et al. New insights into redox response modulation in Fanconi’s anemia cells by hydrogen peroxide and glutathione depletors , 2012, The FEBS journal.
[9] F. Carvalho,et al. Improvement of genetic stability in lymphocytes from Fanconi anemia patients through the combined effect of α-lipoic acid and N-acetylcysteine , 2012, Orphanet Journal of Rare Diseases.
[10] I. Benjamin,et al. Glutathione‐dependent reductive stress triggers mitochondrial oxidation and cytotoxicity , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] A. Figuera,et al. Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations. , 2011, Blood.
[12] A. Csiszar. Anti‐inflammatory effects of resveratrol: possible role in prevention of age‐related cardiovascular disease , 2011, Annals of the New York Academy of Sciences.
[13] S. Pervaiz,et al. Bcl-2 modulates resveratrol-induced ROS production by regulating mitochondrial respiration in tumor cells. , 2010, Antioxidants & redox signaling.
[14] A. Diaspro,et al. Evidence for aerobic ATP synthesis in isolated myelin vesicles. , 2009, The international journal of biochemistry & cell biology.
[15] P. Pedersen,et al. ATP Synthase and the Actions of Inhibitors Utilized To Study Its Roles in Human Health, Disease, and Other Scientific Areas , 2008, Microbiology and Molecular Biology Reviews.
[16] A. Diaspro,et al. Confocal laser scanning microscopy of retinal rod outer segment intact disks: new labeling technique. , 2007, Journal of biomedical optics.
[17] A. Leslie,et al. Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols , 2007, Proceedings of the National Academy of Sciences.
[18] P. Puigserver,et al. Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α , 2006, Cell.
[19] B. Chernyak,et al. Effect of oxidative stress on dynamics of mitochondrial reticulum. , 2006, Biochimica et biophysica acta.
[20] D. Clapp,et al. Continuous in vivo infusion of interferon-gamma (IFN-gamma) preferentially reduces myeloid progenitor numbers and enhances engraftment of syngeneic wild-type cells in Fancc-/- mice. , 2004, Blood.
[21] Z. Dong. Molecular mechanism of the chemopreventive effect of resveratrol. , 2003, Mutation research.
[22] David A. Williams,et al. Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool. , 2002, Experimental hematology.
[23] Jianbiao Zheng,et al. Inhibition of mitochondrial proton F0F1‐ATPase/ATP synthase by polyphenolic phytochemicals , 2000, British journal of pharmacology.
[24] Juliane Jung. Methods Of Enzymatic Analysis , 2016 .
[25] M. Berk,et al. N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. , 2008, Expert opinion on biological therapy.